Nanjing, China · Founded 2013 · Privately Held (backing)
Developer and provider of pharmaceutical R&D services and specialty drug development solutions designed for the discovery and optimization of innovative, modified, and generic medicines. Heron Pharmaceutical is based in Nanjing, China and was founded in 2013. Its last reported valuation was $378 million in Dec 2025. It has raised $46.2 million.
Last reported valuation
$377.9M
Oct 2026
Priced at
—
Total raised
$46.2M
Last round
—
Cap table — not yet on record
Heron Pharmaceutical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Heron Pharmaceutical with a free account
·Watch Heron Pharmaceutical: the Monday email on marks, rounds and moves
